Data / Form D filings / Jade Therapeutics, Inc.
Jade Therapeutics, Inc.: Form D filings
Jade Therapeutics, Inc., a biotechnology company in Salt Lake City, United States, filed 2 Form D notices with the SEC between 2013 and 2014. The latest, on December 31, 2014, reports an offering of $800,000 with nothing sold yet.
Find out what Jade Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 675 ARAPEEN DR., SUITE 302, Salt Lake City, United States, 84108
- Phone
- (646) 918-7479
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1591214
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2014 | New notice | $800,000 | $0 | $800,000 | 0 | Yet to occur | sec.gov |
| Nov 8, 2013 | New notice | $600,000 | $0 | $600,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dinesh Patel | Director | |
| Mary Jane Rafii | Executive Officer, Director | |
| Randall Olson | Director | |
| Barbara Wirostko | Executive Officer, Director | |
| Arthur Klausner | Executive Officer, Director |
Every Form D from the week of Dec 29, 2014 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Jade Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.